Found 47 matching trials
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus PHASE4 Following a transplant for hepatitis C cirrhosis, the infection comes back ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
NY-ESO-1 TCR (TAEST16001)for Patients With Advanced NSCLC PHASE1 TCR-T cell therapy experienced a breakthrough for treating tumors in recent...
Show More Location
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
TIL Therapy for Metastatic Renal Cell Carcinoma PHASE1 Adoptive T cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) has...
Show More Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Learn More & Join Trial
TIL Therapy for Metastatic Ovarian Cancer PHASE1 Adoptive T cell therapy with tumor infiltrating lymphocytes (TIL) has achie...
Show More Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Learn More & Join Trial
Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL) PHASE2 Background:
The presence of T-lymphocytes in resected tumor samples derive...
Show More Location
Vall d'Hebron Institute of Oncology
Learn More & Join Trial
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma PHASE1 This study is to investigate safety and feasibility of a combination therap...
Show More Location
Division of Medical Oncology and Cancer Immunology, University Hospital Basel
Learn More & Join Trial
T-cell Based Immunotherapy for Head and Neck Cancer PHASE1 The aim of this study is to investigate the toxicity and immune response of...
Show More Location
Department of Oncology, Copenhagen University Hospital, Herlev
Learn More & Join Trial
Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma NA The overall purpose of this research study is to find a better way to treat...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute
Learn More & Join Trial
A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients PHASE4 This study is designed to evaluate whether tacrolimus dose reduction in de ...
Show More Learn More & Join Trial
PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma. PHASE1 This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Show More Location
Multiple Locations
Learn More & Join Trial